Edition:
India

Cronos Group Inc (CRON.OQ)

CRON.OQ on NASDAQ Stock Exchange Global Market

6.92USD
1:30am IST
Change (% chg)

$0.04 (+0.58%)
Prev Close
$6.88
Open
$6.89
Day's High
$7.02
Day's Low
$6.67
Volume
133,712
Avg. Vol
--
52-wk High
$10.38
52-wk Low
$5.13

Latest Key Developments (Source: Significant Developments)

Cronos Group Upsizes Bought Deal Financing To $40 Mln
Tuesday, 2 Jan 2018 

Jan 2 (Reuters) - Cronos Group Inc ::CRONOS GROUP INC. ANNOUNCES UPSIZE OF PREVIOUSLY ANNOUNCED BOUGHT DEAL FINANCING TO $40 MILLION.SAYS ‍INCREASED SIZE OF BOUGHT DEAL FINANCING TO ABOUT $40 MILLION GROSS PROCEEDS, REPRESENTING ABOUT 4.6 MILLION SHARES AT $8.75/SHARE​.  Full Article

Cronos Group Announces $30 Million Bought Deal
Tuesday, 2 Jan 2018 

Jan 2 (Reuters) - Cronos Group Inc ::CRONOS GROUP INC. ANNOUNCES $30 MILLION BOUGHT DEAL.CRONOS-ENTERED LETTER OF ENGAGEMENT WITH PI FINANCIAL; UNDERWRITERS TO PURCHASE FOR RE-SALE 3.4 MILLION SHARES OF CO ON "BOUGHT DEAL" BASIS AT $8.75PER SHARE​.  Full Article

Cronos Group Q3 Revenue $1.3 Million
Wednesday, 29 Nov 2017 

Nov 29 (Reuters) - Cronos Group Inc ::CRONOS GROUP INC. REPORTS Q3 2017 FINANCIAL RESULTS.CRONOS GROUP INC - CO GENERATED $1.3 MILLION IN REVENUE DURING THREE-MONTH PERIOD ENDED SEPTEMBER 30, 2017, AN INCREASE OF 104% QUARTER-OVER-QUARTER​.  Full Article

Pharmacan Capital announces $15 million bought deal
Wednesday, 15 Feb 2017 

Pharmacan Capital Corp : Pharmacan Capital announces $15 million bought deal . Has entered into a letter of engagement with eight capital on behalf of a syndicate of underwriters . Pharmacan Capital Corp - underwriters have agreed to purchase 6.7 million common shares of company on a "bought deal" basis at a price per share of $2.25 .Closing date of offering is scheduled to be on or about March 9, 2017.  Full Article

PRESS DIGEST-Canada-March 23

March 23 The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy.